Tharimmune Announces Positive Results for Novel Oral Monoclonal Antibody TH023 Targeting Tumor Necrosis Factor-alpha
BRIDGEWATER, NJ / ACCESS Newswire / March 24, 2025 / Tharimmune, Inc. (Nasdaq:THAR) ("Tharimmune" or the "Company"), a ...
Medscape18d
Anti-TNF-α Therapy with Infliximab in Spondyloarthritides
The increased lymphoma rates observed with anti-TNF therapy may reflect channeling bias, whereby patients with the highest risk of lymphoma preferentially receive anti-TNF therapy. Taken together ...
Nature1y
The risk of herpes zoster: another cost of anti-TNF therapy?
The guidelines advise against vaccination in patients already on active anti-TNF treatment, and recommend vaccination at least 14 days before therapy is started. Based on these recommendations ...
Healio4d
TNF inhibitors do not significantly impact survival in lung, prostate colorectal cancer
TNF inhibitor use demonstrates no negative impact on survival among patients recently diagnosed with colorectal, lung or ...
Medscape4y
Anti-TNF-α Therapy with Infliximab in Spondyloarthritides
After 52 weeks, only one patient had remained in ongoing remission without anti-TNF therapy. Patients who were in partial remission according to the ASAS criteria and those with normal CRP levels ...